It’s been well established that patients with fibromyalgia have a poorer quality of sleep, and now a drug is showing positive results in combatting this common symptom.
For patients with seasonal allergies the prescription medications available may not be enough to help with their symptoms and shots may not be an option they want to consider. Newly developed sublingual immunotherapies have been developed to help these patients manage their daily lives.
Ethnographic study findings indicate that safe spaces represent a promising but so far under-utilized part of community-based HIV prevention infrastructure.
Study shows treatment with golimumab, with or without concomitant methotrexate, reduces symptom severity and improves disease outcomes in patients with psoriatic arthritis. However, adding methotrexate may increase the efficacy of golimumab.
Retrospective analysis of real-world outcomes supports the use of the Amplatzer cardiac plug for left atrial appendage closure in atrial fibrillation patients with a very high risk of stroke or serious bleeds and who cannot tolerate oral anticoagulation.
The risk of developing psoriasis can be attributed to infections, not antibiotic use.
The human immunodeficiency virus (HIV) attacks the immune system and has the power to cause additional conditions – including neurocognitive disorders.
When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.
Interleukin 1 receptor antagonist Anakinra was found to benefit patients afflicted with severe hidradenitis suppurativa, a common skin disorder characterized by excessive inflammation.